Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin for VTE in Cancer Patients
NCT00981903Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Jul 2005
- Primary completion
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of tinzaparin in venous thromboembolism (VTE) (2 arms), sponsored by University of Southern California. Primary endpoint: Development of recurrent venous thromboembolism and major hemorrhage at 6 months. Started Jul 2005; status: terminated.
02
Drugs
tinzaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00981903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981903.